baber/WOPTO huggingface dataset:
Patent DE-69224379-T2 (DE)
Inventor: SHTURMAN LEONID
IPC: A61M25/10
Filed: 1992-04-21
Granted: 1998-07-16
Abstract: A perfusion balloon catheter which permits blood flow through the balloon even when the balloon is inflated. The balloon catheter comprises a thin-walled, collapsible and inflatable tube that has a proximal, generally straight portion, and a distal, helically coiled portion that is generally cylindrically shaped and defines an open lumen therethrough. The successive turns of the coil are secured to one another to maintain the balloon's configuration when inflated. The furled balloon catheter can be inserted to the desired location and then inflated. Because the helically coiled portion defines a relatively large open lumen, blood flow through the balloon can continue even as the inflated balloon remains in place, facilitating extended inflation periods.
Patent DE-69226330-T2 (DE)
Inventor: CHEONG CATHERINE LOUISE
IPC: A61F13/02
Filed: 1992-11-06
Granted: 1999-03-04
Abstract: A wound dressing has a wound-contact layer formed from a polyurethane foam. The foam comprises one part by weight of the reaction product of an isocyanate-capped prepolymer with water (and optionally other hydroxy-functional compounds), and from 0.03 to 0.3 parts by weight of a natural or synthetic rubber. The isocyanate-capped prepolymer is preferably an isocyanate-capped ethyleneoxy/propyleneoxy copolymer, and the rubber is preferably an acrylic rubber.
Patent DE-69228197-T2 (DE)
Inventor: PAREN AARTO
IPC: D01F2/10
Filed: 1992-12-29
Granted: 1999-07-29
Abstract: PCT No. PCT/FI92/00363 Sec. 371 Date Jun. 28, 1994 Sec. 102(e) Date Jun. 28, 1994 PCT Filed Dec. 29, 1992 PCT Pub. No. WO93/13249 PCT Pub. Date Jul. 8, 1993.A product contains silicon dioxide in the form of polysilicic acid in a supporting structure of cellulose. The polysilicic acid contains aluminum silicate sites. In the preparation of the product the cellulose and the silicon dioxide in the form of polysilicic acid are blended to obtain the product in solid form. The obtained blended product is modified with a compound containing aluminum, such as a solution aluminate, which causes the formation of aluminum silicate sites on the polysilicic acid. The cellulose used is viscose cellulose.
Patent DE-69231804-T2 (DE)
Inventor: MIDDLEMAN M
IPC: A61B17/34
Filed: 1992-02-14
Granted: 2001-08-09
Abstract: A device suitable for insertion into a mammalian body comprises an elongated tube 22 or cannula, an elastic member 24 for bending the cannula, and a straightener 26 preventing the elastic member 24 from bending the cannula. The straightener 26 and elastic member 24 are capable of relative axial movement, so that the straightener 26 can be positioned to prevent or allow the elastic from bending the cannula. Preferably the elastic member 24 is formed from a superelastic shape-memory alloy. Other versions of the device without a straightener are desired. <IMAGE>
Patent DE-69233233-T2 (DE)
Inventor: MILLER JOSEPH
IPC: H01F41/18
Filed: 1992-12-16
Granted: 2004-08-26
Abstract: Pt/Co multilayer materials systems having a thin metal interlayer possess superior room temperature coercivity, a square polar Kerr hysteresis loop, sufficient polar Kerr rotation, and are suitable for magneto-optical recording. <??>These material systems allow the recording and writing of information from the substrate side of the multilayer film.
Patent DE-69306591-T2 (DE)
Inventor: MAS JEAN-MANUEL
IPC: C07D263/06
Filed: 1993-10-04
Granted: 1997-04-17
Abstract: PCT No. PCT/FR93/00967 Sec. 371 Date May 3, 1995 Sec. 102(e) Date May 3, 1995 PCT Filed Oct. 4, 1993 PCT Pub. No. WO94/07877 PCT Pub. Date Apr. 14, 1994This invention relates to a method of preparing taxane derivatives of general formula (I) by esterification of protected baccatine III or 10-deacetylbaccatine III by means of an acid of general formula (VII), elimination of protection groupings of the ester obtained, and acylation of the amine function of the side chain. In formulae (I) and (VII): Ar stands for aryl, R is hydrogen or acetyl, R1 is benzoyl or R2-CO-O- in which R2 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, phenyl or heterocyclyl, R3 and R4 may be the same or different and represent hydrogen, alkyl, alkenyl, aralkyl, aryl or alkoxy, and R5 is an alkyl radical substituted by one or more chlorine atoms (2,2,2-trichloroethyl, (2-trichloromethylisopropyl).    <IMAGE>  (I)   <IMAGE>  (VII)
Patent DE-69307249-T2 (DE)
Inventor: ADAMS RONALD D
IPC: A61B17/02
Filed: 1993-09-09
Granted: 1997-06-05
Abstract: A tissue manipulator (50) is provided which is insertable through an endoscopic tube to enable a surgeon to manipulate tissue inside a body cavity. The endoscopic tissue manipulator includes an expandable tissue manipulating frame (80) adapted to expand transversely through a longitudinal slot (72) in a support tube (70) to provide a spatula-shaped platform which can be manipulated by rotation of the support tube about its longitudinal axis to engage and displace large body organs away from a desired surgical site in a body cavity. The frame consists of a plurality of flexible frame members or wires (81) adapted to flex laterally outward through the longitudinal slot in the support tube into a bow-shaped configuration overlapping the other frame members or wires of the spatula-shaped platform. The instrument can be provided with a single tissue manipulating frame or a pair of frames which are expandable through separate longitudinal slots in the support tube to provide a pair of spatula-shaped platforms to engage the tissue. <IMAGE>
Patent DE-69308865-T2 (DE)
Inventor: DUBROEUCQ MARIE-CHRISTINE
IPC: C07K5/06
Filed: 1993-09-06
Granted: 1997-09-11
Abstract: PCT No. PCT/FR93/00847 Sec. 371 Date Mar. 10, 1995 Sec. 102(e) Date Mar. 10, 1995 PCT Filed Sep. 6, 1993 PCT Pub. No. WO94/06825 PCT Pub. Date Mar. 31, 1994This invention relates to compounds of formula (I), in which R denotes a hydrogen atom or a methoxy radical. The invention also concerns the salts of said compounds, their racemic forms, their enantiomers, the preparation of said derivatives and drugs containing same.
Patent DE-69311857-T2 (DE)
Inventor: BARBOSA CELSO ANTONIO
IPC: C22C38/44
Filed: 1993-02-19
Granted: 1998-02-05
Abstract: PCT No. PCT/BR93/00006 Sec. 371 Date Oct. 26, 1993 Sec. 102(e) Date Oct. 26, 1993 PCT Filed Feb. 19, 1993 PCT Pub. No. WO93/17144 PCT Pub. Date Sep. 2, 1993.A metastable austenitic, cold deformed "work hardened stainless steel for springs", with 17.0 to 19.0% Cr, 8.0 to 10.0% Ni, up to 0.03% C, 0.006 to 0.16% N, up to 1.0% Si, 1.0 to 2.0% Mn, up to 0.8% Mo, up to 0.045% P, up to 0.030% S, iron (Fe) and residuals, the alloy being used for spring manufacture, exhibiting good resistance to corrosion after cold deformation, exhibiting high mechanical properties and better resistance to corrosion than UNS S30200 steel, even when exposed to a tempered heat treatment. The steel is appropriate for use as wire rod, bars, wires, sheets and strip forms.
Patent DE-69314993-T2 (DE)
Inventor: NERI CARLO
IPC: C08J3/22
Filed: 1993-06-01
Granted: 1998-04-09
Abstract: Solid blends of stabilizers for polymers including an organic polymer and at least one siliconic compound having a sterically hindered amine group in the molecule in quantities of between 40% and 90% by weight of the final solid blend.
Patent DE-69330952-T2 (DE)
Inventor: LARSEN E
IPC: E06B3/667
Filed: 1993-03-18
Granted: 2002-03-28
Abstract: An insulating glass unit is shown comprising a pair of generally parallel, spaced-apart glass panes and a spacer peripherally joining the glass panes to each other. The spacer is a tubular structure, and may include a particulate desiccant filling at least a section of the interior and conforming to the interior configuration thereof to contribute compressive strength to the spacer. The spacer desirably is made from stainless steel sheeting having a thickness not greater than about 0.005 inches. In a preferred embodiment, the spacer includes side walls sealed to the glass panes and an outer wall extending between the side walls and having a sealant free portion between the side walls that extends substantially completely about the periphery of the glass unit.
Patent DE-69331454-T2 (DE)
Inventor: SPANKE RONALD ANTHONY
IPC: H04L12/56
Filed: 1993-06-03
Granted: 2002-08-01
Abstract: In an arrangement where a switching system receives parameter(s) concerning the traffic expected on a call from a first user to a second user, the system determines a priority for the call based on the expected traffic parameter(s), and information is transmitted to the second user during the call based on the determined priority and with less than a maximum jitter. The priority is selected from a predefined priority table based on expected traffic parameters. The priority table is usable for both constant bit rate and statistical calls.
Patent DE-69400455-T2 (DE)
Inventor: ABONDANCE ROGER
IPC: A63C5/07
Filed: 1994-04-13
Granted: 1997-02-06
Abstract: This ski includes longitudinal reinforcing elements (9) each bearing on an edge (8), and forming the side walls of the ski, which extend, at least in the case of one of them, over a part of the height of the latter, and a shell (10) forming the topsheet (upper face) and a part of at least one of the lateral walls of the ski, and the longitudinal sides (12) of which rest and are fastened on the topsheet of the side walls (9), the respective heights of a side wall and of the shell over at least one of the side faces of the ski varying in the same proportions over the length of the ski. <IMAGE>
Patent DE-69405015-T2 (DE)
Inventor: BUCHANAN FRASER
IPC: C03C8/14
Filed: 1994-12-16
Granted: 1998-01-15
Abstract: PCT No. PCT/GB94/02749 Sec. 371 Date Aug. 23, 1996 Sec. 102(e) Date Aug. 23, 1996 PCT Filed Dec. 16, 1994 PCT Pub. No. WO95/18076 PCT Pub. Date Jul. 6, 1995A glaze composition for refractory materials includes 30 to 80% by weight of at least one lead-free and barium-free borosilicate, borophosphate or phosphate glass frit having a dilatometric softening point of below 600 DEG  C.; 2 to 30% by weight of aluminium powder or an aluminium alloy powder; 2 to 30% by weight of silicon powder or silicon alloy powder, up to 10% by weight of an inhibitor; and optionally a refractory filler, a clay or other additives. The glaze composition is of particular use as a glaze for carbon containing refractory materials such as submerged entry nozzles and graphite electrodes.
Patent DE-69409473-T2 (DE)
Inventor: ITOH KATSUMI
IPC: A61P31/10
Filed: 1994-09-22
Granted: 1998-07-30
Abstract: The present invention provides an azole compound represented by the formula (I): <CHEM> , wherein Ar is an optionally-substituted phenyl group; R<1> and R<2> are, the same or different, a hydrogen atom or a lower alkyl group, or R<1> and R<2> may combine together to form a lower alkylene group; R<3> is a hydrogen atom or an acyl group; Y is a nitrogen atom or a methine group; and A is an optionally-substituted saturated cyclic amide group bonded through a first nitrogen atom, or a salt thereof, which is useful for prevention and therapy of fungal infections of mammals as antifungal agent.
Patent DE-69418409-T2 (DE)
Inventor: WEBB MONTY F
IPC: H01L29/861
Filed: 1994-07-25
Granted: 1999-09-16
Abstract: An overvoltage protection device having multiple shorting dots (66) in the emitter region and multiple buried regions (72) substantially aligned with these shorting dots. The placement, number, and area of these buried regions reduce and more accurately set the overshoot voltage value of the device while maintaining the high surge capacities of the device. Further, doping types and concentrations have been modified from that known in the prior art to reduce overshoot providing a more accurate and sensitive overvoltage protection device than that known previously in the prior art. The emitter regions (68) are preferably p<+><+> doped, the upper base (70) is n<+> doped, the mid-region layer (74) is p-doped, with the burred regions (72) being p<+> doped, the lower base region (76) is n<+> doped and contains a "getter" region (78) of higher doping to reduce the leakage current. <IMAGE>
Patent DE-69420404-T2 (DE)
Inventor: KIROL LANCE
IPC: F25B17/08
Filed: 1994-04-20
Granted: 2000-02-10
Abstract: In a sorption reaction system comprising one or more first reactors (10) in which a refrigerant is alternately adsorbed and desorbed, and one or more second reactors (20) in which a refrigerant is alternately desorbed and adsorbed, respectively, and having a cooling loop (16, 60, 68, 67, 56, 12, 21) for directing heat transfer fluid to and from said reactors (10, 20), a method of cooling an adsorbing reactor comprises directing liquid phase heat transfer fluid having a phase change from liquid to gas at a temperature at or below the temperature of adsorption to an adsorbing reactor in heat exchange exposure to the adsorbent utilizing vaporized heat transfer fluid for driving the liquid heat transfer fluid in the cooling loop. The refrigerant may be used as the heat transfer fluid. The invention includes apparatus for carrying out the method.
Patent DE-69424789-T2 (DE)
Inventor: CATT MICHAEL
IPC: G01N33/76
Filed: 1994-06-24
Granted: 2000-11-23
Abstract: A method of monitoring the status of a current ovulation cycle of an individual female mammalian (generally human) subject, involving repeated testing of the body fluid concentration of at least one analyte, preferably estrone-3-glucuronide (E3G) of significance in relation to the status of the ovulation cycle, during at least the pre-ovulation phase of the current ovulation cycle of the individual subject, wherein testing for said analyte concentration during the current ovulation cycle conducted at least once during the interval spanning days 1 to 7 inclusive following the onset of menses, to establish a reference concentration value for analyte in the current cycle, and then testing is conducted repeatedly during a plurality of days, preferably commencing at least 5 numerical days in advance of the mean numerical day on which actual ovulation has occurred over one or more previous ovulation cycles in the same individual subject, analyte concentration values obtained during said repeated testing being compared with the reference concentration value to determine whether a concentration change indicative of imminent ovulation is occurring or has occurred since the previous test. The method can be based solely on E3G measurements.
Patent DE-69426673-T2 (DE)
Inventor: DEAN RICHARD T
IPC: A61K38/31
Filed: 1994-06-03
Granted: 2001-09-20
Abstract: This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (<sup>186</sup>Re) and rhenium-188 (<sup>188</sup>Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.
Patent DE-69431073-T2 (DE)
Inventor: VAN DER SLEESEN MICHAEL F
IPC: A41D27/28
Filed: 1994-04-14
Granted: 2003-03-27
Abstract: A ventilated garment is provided having at least one substantially non-stretchable front panel (106) and at least one rear panel (310), in which the front and rear panels have an opening therein, and in which the front panel includes a substantially non-stretchable, air permeable vent panel (210), having a shape substantially corresponding to the front panel opening (108), affixed to the front panel along the periphery of the front panel opening. The front panel further includes a cover element (110). First, second, and third closure elements are provided along the cover element periphery (114, 116, 118) to adjustably couple the cover element to the front panel.
Patent DE-69431166-T2 (DE)
Inventor: LAX INGEMAR
IPC: A61B19/00
Filed: 1994-06-13
Granted: 2003-05-08
Abstract: PCT No. PCT/SE94/00574 Sec. 371 Date Nov. 3, 1995 Sec. 102(e) Date Nov. 3, 1995 PCT Filed Jun. 13, 1994 PCT Pub. No. WO94/28817 PCT Pub. Date Dec. 22, 1994A stereotactical instrument for identifying a spatial position of an area in a patient's body which is to be subjected to treatment, preferably radiation treatment, the position of the area being previously determined, for example, by an angiogram, PET, DSA, CT, MRI, or X-ray equipment. The instrument includes a non-yielding and radiolucent frame which is arranged to support the patient's body and to support an indicating device, a radiolucent fixing device which is arranged inside the frame and on which the patient's body is intended to rest, the fixing device including a flexible casing which contains a yieldable substance, at a first stage the fixing device being adapted to permit that the patient is oriented in a desired position, partly sunk into the fixing device, and at a second stage the yieldable substance of the fixing device being given a non-yielding state, thereby fixing the patient in the desired position, and a partially non-radiolucent orienting device which is mounted on at least one longitudinal side of the frame and which is adapted to indicate the position of an image sectional plane through the area in the patient's body.
Patent DE-69433899-T2 (DE)
Inventor: ZEHAVI EPHRAIM
IPC: H04B1/707
Filed: 1994-10-26
Granted: 2005-08-04
Abstract: A communication system for transmitting variable rate data is disclosed wherein redundancy is added to the variable rate data to provide repetition symbols. The repetition symbol data is transmitted with symbol energy scaled in accordance to the rate of the variable rate data when the variable rate data is greater than or equal to a nominal data rate. When the variable rate data is less than the nominal data rate, the symbol data is transmitted at nominal symbol energy and redundancy is removed by transmission gating of a proportion of the transmission symbol data determined in accordance with the rate of the variable rate data. Furthermore, a receiver for receiving the variable rate data is disclosed which uses the redundancy in the transmitted data symbol stream to make a corrected estimate of the transmitted symbol data.
Patent DE-69434428-T2 (DE)
Inventor: HONJO TASUKU
IPC: C07K14/475
Filed: 1994-10-13
Granted: 2006-05-24
Abstract: The polypeptides of the present invention is produced and secreted in pro-B cells, so it may be used for diseases relating to undergrown or abnormal proliferation of hematopoietic cells, neuronal enhancement or depression, immunological enhancement and depression, for example, inflammatory diseases (rheumatoid arthritis, ulcerative colitis etc.), hematopoietic stemcytopenia after bone marrow transplantation, leukocytopenia, thrombocytopenia, B lymphopenia and T lymphopenia after chemotherapy, anemia, infectious diseases, cancer, leukocytosis, AIDS, neurodegenerative diseases (Alzheimer, multiple sclerosis etc.), prevention or treatment of neuronal injury, prevention or treatment of disorder of bone metabolism (osteoporosis etc.) or tissue repair. The DNA of the present invention may be utilized as an important and essential template in preparing the polypeptide of the present invention which is expected to possess various use or for diagnosis of and in the treatment of gene diseases.
Patent DE-69501314-T2 (DE)
Inventor: GILCHRIST THOMAS
IPC: A61K33/00
Filed: 1995-06-02
Granted: 1998-07-23
Abstract: PCT No. PCT/GB95/01275 Sec. 371 Date Mar. 7, 1996 Sec. 102(e) Date Mar. 7, 1996 PCT Filed Jun. 2, 1995 PCT Pub. No. WO95/33477 PCT Pub. Date Dec. 14, 1995The invention discloses fluids for use in medical dialysis procedures which contain proteolytic hydrolysates of one or more proteins (e.g. casein) as effective osmotic agent and bicarbonate ions as buffering agent. Additionally the dialysis fluid contains physiological salts.
Patent DE-69504108-T2 (DE)
Inventor: STRADI ARISTIDE
IPC: B65H3/22
Filed: 1995-11-29
Granted: 1999-04-15
Abstract: A device for raising an edge of a topmost sheet from a pile of sheets comprises two cursors slidably coupled to a mobile head. On one end of each cursor two needles are fixed, which needles pierce into said edge. The device is especially useful in the manufacturing process of phenolic-melaminic decorative plastic laminates and preformable or postformable treated panels for raising sheets of paper which have been impregnated with resin and piled one on another.
Patent DE-69514236-T2 (DE)
Inventor: CORFITSEN STEN
IPC: B60K15/04
Filed: 1995-08-04
Granted: 2000-06-15
Abstract: PCT No. PCT/SE95/00909 Sec. 371 Date Feb. 10, 1997 Sec. 102(e) Date Feb. 10, 1997 PCT Filed Aug. 4, 1995 PCT Pub. No. WO96/05136 PCT Pub. Date Feb. 22, 1996A docking arrangement for the automatic fueling of automotive vehicles, primarily cars, where a robot is provided including a robot head that can be moved in relation to the robot and positioned in relation to an adapter (3), the adapter being arranged for fastening to the upper orifice of the fuel-tank pipe (2) of a vehicle. According to the invention the robot head includes a rearward part (13) and a front part (14) as seen in its axial direction, wherein the rearward part (13) is attached to the robot and the front part (14) is carried by the rearward part (13) with the aid of a spring (15) which enables the front part (14) to be moved from a rest position towards the rearward part (13) and angled relative to the rearward part; in that the front part (14) has an axially forwardly projecting flange (16) which extends along a lower part (17) of the periphery (18) of the front part and which fits on the mantle surface (19) of the adapter (3; 39) and in that when docking the front part (14) with the adapter (3; 39), the flange (16) will lie in abutment with the mantle surface (19) of the adapter, whereby the front part (14) is angled against the spring force at an angle at which the adapter and the front part will lie in abutment with one another.
Patent DE-69516569-T2 (DE)
Inventor: CHOPIN THIERRY
IPC: C01F17/00
Filed: 1995-02-08
Granted: 2001-01-04
Abstract: A new sol compsn. which comprises:- oxide particles of a tetravalent metal; an amphiphilic acid system, and a diluent in which the particles have a d90 no more than 200 nm, and the sol has at least one of the following characteristics:- the oxide particles are in the form of crystallite agglomerates (CeO2) which the crystallites have a d80 (pref. d90), measured by photometric counting (HR transmission electronic microscopy) of no more than 5nm, 90% of the agglomerates comprising 1-5 (pref. 1-3) crystallites. The amphiphilic system comprises at least one 11-50C acid and has at least one branching in the alpha-beta or gamma position to the acidic H. The use of the prods. as additives to gas oil fuels is also claimed.
Patent DE-69516706-T2 (DE)
Inventor: VIAL HENRI
IPC: A61K31/4412
Filed: 1995-10-13
Granted: 2000-11-23
Abstract: PCT No. PCT/FR95/01349 Sec. 371 Date Jul. 2, 1997 Sec. 102(e) Date Jul. 2, 1997 PCT Filed Oct. 13, 1995 PCT Pub. No. WO96/11910 PCT Pub. Date Apr. 25, 1996Substituted bis-2-aminopyridines of formula (1), wherein Q, R1,R2,R3,R4 are as defined in the specification. A method for preparing said compounds and the use thereof as a drug and in particular as active drugs for controlling parasiticc infections within red blood cells, e.g. malaria or babesiasis.    <IMAGE>  (1)